Adagio(IVVD) - 2022 Q1 - Quarterly Report
Adagio(IVVD)2022-05-13 12:01(Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q Commission File Number: 001-40703 Adagio Therapeutics, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 85-1403134 (State or other jurisdiction of incorporation or organiz ...